Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    01508910
Show Display Options
Rank Status Study
1 Active, not recruiting Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Conditions: Chronic Myocardial Ischemia;   Refractory Angina Pectoris;   (Advanced) Coronary Heart Disease
Interventions: Biological: Auto-CD34+ cells;   Biological: Placebo: Diluent used to suspend Auto-CD34+ cells;   Other: Standard of care

Indicates status has not been verified in more than two years